Select a community
All Communities
Home > Community Treatment Reports > Budeprion XL (bupropion) Treatment Report
What is Budeprion XL?

Budeprion XL® is an extended-release version of bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used for the treatment of depression. It is also approved for the prevention of seasonal affective disorder.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
4 36%
None
7 64%

Most commonly reported side effects

dry mouth
2 18%
Headaches
1 9%
hand tremors
1 9%
Weight loss
1 9%
  • Mild
  • Moderate
  • Severe

Dosages

  100 mg daily 150 mg/24 hours daily 150 mg daily 200 mg daily 300 mg/24 hours daily 300 mg daily 3 x 150 mg/24 hours daily 450 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 17 Number of Patients: 17 17 Number of Patients: 17 3 Number of Patients: 3 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Budeprion XL (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
3 33% Other: 33%
Did not seem to work
2 22% Did not seem to work: 22%
Doctor's advice
2 22% Doctor's advice: 22%
Side effects too severe
2 22% Side effects too severe: 22%
Expense
1 11% Expense: 11%

See all 9 patients who’ve stopped taking Budeprion XL

Currently Taking Budeprion XL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
1
5
9
8

Stopped Taking Budeprion XL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
2
0
1
1
3

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
8 73%
Usually
3 27%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
11 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
9 82%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.